The mTOR inhibitor rapamycin synergizes with a fatty acid synthase inhibitor to induce cytotoxicity in ER/HER2-positive breast cancer cells.

by Chen Yan, Huang Wei, Zheng Minjuan, Xue Yan, Yang Jingyue, Liu Wenchao, Han Sheng
Published 2014-01-01